160 related articles for article (PubMed ID: 24533067)
41. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.
Hippisley-Cox J; Coupland C
BMJ Open; 2015 Mar; 5(3):e007825. PubMed ID: 25783428
[TBL] [Abstract][Full Text] [Related]
42. Meat consumption and risk of colorectal cancer.
Chao A; Thun MJ; Connell CJ; McCullough ML; Jacobs EJ; Flanders WD; Rodriguez C; Sinha R; Calle EE
JAMA; 2005 Jan; 293(2):172-82. PubMed ID: 15644544
[TBL] [Abstract][Full Text] [Related]
43. Inclusion of a Genetic Risk Score into a Validated Risk Prediction Model for Colorectal Cancer in Japanese Men Improves Performance.
Iwasaki M; Tanaka-Mizuno S; Kuchiba A; Yamaji T; Sawada N; Goto A; Shimazu T; Sasazuki S; Wang H; Marchand LL; Tsugane S;
Cancer Prev Res (Phila); 2017 Sep; 10(9):535-541. PubMed ID: 28729251
[TBL] [Abstract][Full Text] [Related]
44. Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes.
Overbeek JA; Kuiper JG; van der Heijden AAWA; Labots M; Haug U; Herings RMC; Nijpels G
Int J Colorectal Dis; 2019 Feb; 34(2):269-276. PubMed ID: 30421309
[TBL] [Abstract][Full Text] [Related]
45. Model for assessing cardiovascular risk in a Korean population.
Park GM; Han S; Kim SH; Jo MW; Her SH; Lee JB; Lee MS; Kim HC; Ahn JM; Lee SW; Kim YH; Kim BJ; Koh JM; Kim HK; Choe J; Park SW; Park SJ
Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):944-51. PubMed ID: 25351481
[TBL] [Abstract][Full Text] [Related]
46. Colorectal cancer statistics, 2017.
Siegel RL; Miller KD; Fedewa SA; Ahnen DJ; Meester RGS; Barzi A; Jemal A
CA Cancer J Clin; 2017 May; 67(3):177-193. PubMed ID: 28248415
[TBL] [Abstract][Full Text] [Related]
47. One-year mortality of colorectal cancer patients: development and validation of a prediction model using linked national electronic data.
Cowling TE; Bellot A; Boyle J; Walker K; Kuryba A; Galbraith S; Aggarwal A; Braun M; Sharples LD; van der Meulen J
Br J Cancer; 2020 Nov; 123(10):1474-1480. PubMed ID: 32830202
[TBL] [Abstract][Full Text] [Related]
48. A prediction model of Nephrolithiasis Risk: A population-based cohort study in Korea.
Mukasa D; Sung J
Investig Clin Urol; 2020 Mar; 61(2):188-199. PubMed ID: 32158970
[TBL] [Abstract][Full Text] [Related]
49. Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada.
Gao RN; Neutel CI; Wai E
J Public Health (Oxf); 2008 Jun; 30(2):194-201. PubMed ID: 18445612
[TBL] [Abstract][Full Text] [Related]
50. Iron intake and the risk of colorectal cancer.
Wurzelmann JI; Silver A; Schreinemachers DM; Sandler RS; Everson RB
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):503-7. PubMed ID: 8827353
[TBL] [Abstract][Full Text] [Related]
51. Isoflavone and Soyfood Intake and Colorectal Cancer Risk: A Case-Control Study in Korea.
Shin A; Lee J; Lee J; Park MS; Park JW; Park SC; Oh JH; Kim J
PLoS One; 2015; 10(11):e0143228. PubMed ID: 26575841
[TBL] [Abstract][Full Text] [Related]
52. Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study.
Akhter M; Inoue M; Kurahashi N; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2128-35. PubMed ID: 18708407
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
[No Abstract] [Full Text] [Related]
54. Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea.
Khil H; Kim SM; Hong S; Gil HM; Cheon E; Lee DH; Kim YA; Keum N
Sci Rep; 2021 Jan; 11(1):2413. PubMed ID: 33510236
[TBL] [Abstract][Full Text] [Related]
55. Fasting serum glucose level and cancer risk in Korean men and women.
Jee SH; Ohrr H; Sull JW; Yun JE; Ji M; Samet JM
JAMA; 2005 Jan; 293(2):194-202. PubMed ID: 15644546
[TBL] [Abstract][Full Text] [Related]
56. A clinical prediction nomogram to assess risk of colorectal cancer among patients with type 2 diabetes.
Feng LH; Su T; Bu KP; Ren S; Yang Z; Deng CE; Li BX; Wei WY
Sci Rep; 2020 Sep; 10(1):14359. PubMed ID: 32873885
[TBL] [Abstract][Full Text] [Related]
57. Can composite performance measures predict survival of patients with colorectal cancer?
Chung KP; Chen LJ; Chang YJ; Chang YJ
World J Gastroenterol; 2014 Nov; 20(42):15805-14. PubMed ID: 25400466
[TBL] [Abstract][Full Text] [Related]
58. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.
Kim DH; Cha JM; Shin HP; Joo KR; Lee JI; Park DI
J Clin Gastroenterol; 2015 Jan; 49(1):41-9. PubMed ID: 24583751
[TBL] [Abstract][Full Text] [Related]
59. Smoking status before and after colorectal cancer diagnosis and mortality in Korean men: A population-based cohort study.
Jang D; Choe S; Park JW; Jeong SY; Shin A
Cancer Med; 2020 Dec; 9(24):9641-9648. PubMed ID: 33230884
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
